We are happy to announce that the production of recombinant human Histone H3 is almost completed. In collaboration with Maastricht University, we have developed a recombinant production process for human Histone H3, providing a safe and effective alternative compared to the Histones obtained from animal products.
Recent studies have highlighted the significant role of Histone H3 in various diseases, including sepsis, cancer, and genetic disorders. Our recombinant Histone H3 offers an excellent resource for laboratories in both academia and industry, seeking high-quality recombinant proteins for their research projects.
We look forward to your inquiries and are eager to support your research endeavors.
Need more information? Please contact us via biotech@basicpharma.nl or +31 (0)88 255 40 10!
